CAS No. 737789-87-6
Batch:
Purity:99.76
Chemical Structure
Check the
Relugolix (TAK-385, RVT-601)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
| IUPAC Name | 1-[4-[1-[(2,6-difluorophenyl)methyl]-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-3-methoxyurea | |
|---|---|---|
| CAS Number | 737789-87-6 | |
| Molecular Formula |
C29H27F2N7O5S |
|
| Molecular Weight (MW) | 623.63 | |
| SMILES | CN(C)CC1=C(SC2=C1C(=O)N(C(=O)N2CC3=C(C=CC=C3F)F)C4=NN=C(C=C4)OC)C5=CC=C(C=C5)NC(=O)NOC | |
| InChIKey | AOMXMOCNKJTRQP-UHFFFAOYSA-N |
Relugolix (TAK-385) is a selective, non-peptide antagonist of the gonadotropin-releasing hormone receptor (GnRHR), demonstrating potent inhibition against human GnRHR and monkey GnRHR. By competitively binding to pituitary GnRHR, it blocks endogenous GnRH signaling, preventing the secretion of luteinizing hormone and follicle-stimulating hormone, which downstream suppresses gonadal sex hormone production. [1]
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
61 mg/mL
(97.81 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
100 mg/mL
(160.35 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
- Relugolix (TAK-385, RVT-601) Clinical Trials
- Relugolix (TAK-385, RVT-601) Solubility in DMSO
- Relugolix (TAK-385, RVT-601) Stock Solution
- Relugolix (TAK-385, RVT-601) Storage
- Relugolix (TAK-385, RVT-601) Stability
- Relugolix (TAK-385, RVT-601) Molecular Weight
- Relugolix (TAK-385, RVT-601) SMILES
- Relugolix (TAK-385, RVT-601) Chemical Structure (2D and 3D)
- Relugolix (TAK-385, RVT-601) SDS|MSDS
Note: Technical data last updated: Sep 1, 2026.